TTOO - T2 Biosystems rises 14% after multiple new studies show rapid disease detection

• T2 Biosystems ( NASDAQ: TTOO ) is trading 14% higher after the company said studies showed positive data for the use of T2 Biosystems’ products, T2 Magnetic Resonance Technology.
• The company said the T2 Biosystems’ products can quickly and accurately detect sepsis-causing pathogens within adult patient blood samples without the need to wait hours for a positive blood culture.
• The studies showed combining T2Bacteria and T2Candida panels for diagnosing intra-abdominal infections had the ability to detect more infections than blood culture.

For further details see: